SBI Pharma Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : SBI Mutual Fund
Aum(Rs Cr) : 65.14
NAV 26 May 2017 124.31 0.00
(0.00%)

NAV High-Low (in Rs)

ONE Mth 946.93
946.93
52-WEEk 946.93
1086.94

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - - 16.94
Sensex 1.85 2.97 17.9 17.68 25.53
Nifty 1.77 2.6 18.25 18.9 30.39

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 65.14 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Tanmaya Desai

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Apr 2017
Category Share (%)
Cash & Bank Balance & Bank Deposits 0.10
CBLO 4.70
Equity 92.97
Net CA & Others 2.23
› More
   As On 30 Apr 2017
Sector Name Amount
Healthcare 5.08
Miscellaneous 4.32
NA 7.03
Pharmaceuticals - Indian - Bulk Drugs 20.12
Pharmaceuticals - Indian - Bulk Drugs & Formln 55.76
Pharmaceuticals - Indian - Formulations 5.03
Pharmaceuticals - Multinational 2.66
› More
   As On 30 Apr 2017
Company Name
Sun Pharma.Inds. 12.20
Strides Shasun 10.20
Aurobindo Pharma 8.97
Lupin 8.48
Cipla 7.06
Glenmark Pharma. 5.67
Torrent Pharma. 4.49
Thyrocare Tech. 4.32
› More

Fund DETAILS

Asset Management Co.

Registered Address

SBI Funds Management Ltd,

9th floorCrescenzoC-39&39
G BlockBandra-kurla complex
Bandra (east)Mumbai-400 051.

Phone: 022-61793000 | Fax: 022-2218 9663

Email: partnerforlife@sbimf.com

Website: www.sbimf.com